抗血小板药物作用机制及相关问题

被引：26

作者：

李娟 ^{[1
,2
]}

李春坚 ^{[1
]}

机构：

[1] 南京医科大学第一附属医院(江苏省人民医院)心脏科

[2] 不详

来源：

中国实用内科杂志 | 2015年 / 35卷 / 01期

关键词：

抗血小板药物; 作用机制; 个体化治疗;

D O I：

暂无

中图分类号：

R96 [药理学];

学科分类号：

100602 ; 100706 ;

摘要：

抗血小板治疗是冠心病、缺血性脑卒中等血栓栓塞性疾病最重要的治疗措施之一。近十余年,随着抗栓领域基础研发及临床研究的逐步深入,出现了诸多新的抗血小板药物。文章综述了各种抗血小板药物的作用机制及临床应用中的相关问题,为实施规范化、个体化抗血小板治疗提供参考。

引用

页码：8 / 13

页数：6

共 8 条

[1]

Response Variability to P2Y 12 Receptor Inhibitors[J] . Jolanta M. Siller-Matula,Dietmar Trenk,Karsten Schr?r,Meinrad Gawaz,Steen D. Kristensen,Robert F. Storey,Kurt Huber.JACC: Cardiovascular Interventions . 2013 (11)

[2]

Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Severe Renal Impairment[J] . Kathleen Butler,Renli Teng.Journal of Clinical Pharmacology . 2012 (9)

[3]

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers[J] . Andrew L. Frelinger,Ronald D. Lee,Darcy J. Mulford,Jingtao Wu,Sai Nudurupati,Anu Nigam,Julie K. Brooks,Deepak L. Bhatt,Alan D. Michelson.Journal of the American College of Cardiology . 2012 (14)

[4]

A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y12 Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention[J] . Robert C. Welsh,Sunil V. Rao,Uwe Zeymer,Vivian P. Thompson,Kurt Huber,Janusz Kochman,Matthew W. McClure,Daniel D. Gretler,Deepak L. Bhatt,C. Michael Gibson,Dominick J. Angiolillo,Paul A. Gurbel,Lisa G. Berdan,Gayle Paynter,Sergio Leonardi,Mina Madan,Willia

[5]

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization[J] . David E. Winchester,Xuerong Wen,William D. Brearley,Ki E. Park,R. David Anderson,Anthony A. Bavry.Journal of the American College of Cardiology . 2011 (10)

[6]

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial[J] . Shamir R Mehta,Jean-Francois Tanguay,John W Eikelboom,Sanjit S Jolly,Campbell D Joyner,Christopher B Granger,David P Faxon,Hans-Jurgen Rupprecht,Andrzej Budaj,Alvaro Avezum,Petr Widimsky,Philippe Gabriel Steg,Jean-Pierre Bassand,Gilles Montalescot,Carlos Macaya,Giuseppe Di

[7] Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate [J].

Bonello, Laurent ;

Tantry, Udaya S. ;

Marcucci, Rossella ;

Blindt, Ruediger ;

Angiolillo, Dominick J. ;

Becker, Richard ;

Bhatt, Deepak L. ;

Cattaneo, Marco ;

Collet, Jean Philippe ;

Cuisset, Thomas ;

Gachet, Christian ;

Montalescot, Gilles ;

Jennings, Lisa K. ;

Kereiakes, Dean ;

Sibbing, Dirk ;

Trenk, Dietmar ;

Van Werkum, Jochem W. ;

Paganelli, Franck ;

Price, Matthew J. ;

Waksman, Ron ;

Gurbel, Paul A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (12) :919-933

[8] Pharmacology of emerging novel platelet inhibitors [J].

Angiolillo, Dominick J. ;

Capranzano, Piera .

AMERICAN HEART JOURNAL, 2008, 156 (02) :S10-S15

← 1 →